Study: NCT05370599

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anti-hypertensive agent: amlodipine
Description: Patients with hypertension will be randomly assigned to be treated with amlodipine, chlorthalidone, or losartan. All drugs will be initiated at the lowest dose and uptitrated as needed to achieve standard BP targets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-hypertensive agent: amlodipine
Description: Patients with hypertension will be randomly assigned to be treated with amlodipine, chlorthalidone, or losartan. All drugs will be initiated at the lowest dose and uptitrated as needed to achieve standard BP targets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-hypertensive agent: amlodipine
Description: Patients with hypertension will be randomly assigned to be treated with amlodipine, chlorthalidone, or losartan. All drugs will be initiated at the lowest dose and uptitrated as needed to achieve standard BP targets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-hypertensive agent: Chlorthalidone
Description: Patients with hypertension will be randomly assigned to be treated with amlodipine, chlorthalidone, or losartan. All drugs will be initiated at the lowest dose and uptitrated as needed to achieve standard BP targets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-hypertensive agent: Chlorthalidone
Description: Patients with hypertension will be randomly assigned to be treated with amlodipine, chlorthalidone, or losartan. All drugs will be initiated at the lowest dose and uptitrated as needed to achieve standard BP targets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-hypertensive agent: Chlorthalidone
Description: Patients with hypertension will be randomly assigned to be treated with amlodipine, chlorthalidone, or losartan. All drugs will be initiated at the lowest dose and uptitrated as needed to achieve standard BP targets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-hypertensive agent: Losartan
Description: Patients with hypertension will be randomly assigned to be treated with amlodipine, chlorthalidone, or losartan. All drugs will be initiated at the lowest dose and uptitrated as needed to achieve standard BP targets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-hypertensive agent: Losartan
Description: Patients with hypertension will be randomly assigned to be treated with amlodipine, chlorthalidone, or losartan. All drugs will be initiated at the lowest dose and uptitrated as needed to achieve standard BP targets.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-hypertensive agent: Losartan
Description: Patients with hypertension will be randomly assigned to be treated with amlodipine, chlorthalidone, or losartan. All drugs will be initiated at the lowest dose and uptitrated as needed to achieve standard BP targets.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Home BP monitoring with cuffed device
Description: Patients will be randomized to monitor their blood pressure either with a BP cuffed device alone, versus with either or use of a BP monitoring patch or BP monitoring watch.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home BP monitoring with cuffed device
Description: Patients will be randomized to monitor their blood pressure either with a BP cuffed device alone, versus with either or use of a BP monitoring patch or BP monitoring watch.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home BP monitoring with cuffed device
Description: Patients will be randomized to monitor their blood pressure either with a BP cuffed device alone, versus with either or use of a BP monitoring patch or BP monitoring watch.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home BP monitoring with cuffed device + BP patch
Description: Patients will be randomized to monitor their blood pressure either with a BP cuffed device alone, versus with either or use of a BP monitoring patch or BP monitoring watch.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home BP monitoring with cuffed device + BP patch
Description: Patients will be randomized to monitor their blood pressure either with a BP cuffed device alone, versus with either or use of a BP monitoring patch or BP monitoring watch.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home BP monitoring with cuffed device + BP patch
Description: Patients will be randomized to monitor their blood pressure either with a BP cuffed device alone, versus with either or use of a BP monitoring patch or BP monitoring watch.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home BP monitoring with cuffed device + BP watch
Description: Patients will be randomized to monitor their blood pressure either with a BP cuffed device alone, versus with either or use of a BP monitoring patch or BP monitoring watch.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home BP monitoring with cuffed device + BP watch
Description: Patients will be randomized to monitor their blood pressure either with a BP cuffed device alone, versus with either or use of a BP monitoring patch or BP monitoring watch.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home BP monitoring with cuffed device + BP watch
Description: Patients will be randomized to monitor their blood pressure either with a BP cuffed device alone, versus with either or use of a BP monitoring patch or BP monitoring watch.